IL17A and inflammatory bowel disease: Importantly, whether these double-positive IL17A+FOXP3+ T cell subset harbors an immunoregulatory/suppressive function or, alternatively, might even convert into pro-inflammatory/pathogenic effectors during the pathophysiology of IBD remains an open question.